HRTS logo

HRTS
Tema Heart & Health ETF

74
Volume
5,395.00
52W High
$36.65
52W Low
$27.05
50D MA
$33.64
Prev Close
$34.36
Loading...
Loading...
News
all
press releases
News Placeholder
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain
Eli Lilly and Novo Nordisk are accelerating global obesity pill launches as rising GLP-1 demand puts weight-loss ETFs in focus.
News Placeholder
Ascendis Pharma Eyes Best Open In A Month After Q4 Print, But BofA Cuts Price Target: Retail Gets Buzzing
The brokerage adjusted its 2025 Yorvipath sales forecast downward, expecting a more backloaded ramp.
News Placeholder
Keros Therapeutics Stock Heads For Record Low After Dosing Halt In Pulmonary Disease Trial, Retail Buzz Spikes
The company’s stock declined nearly 60% in 2024 and has lost an additional 21% in 2025, with this latest setback further dampening investor confidence.
<
...
1
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available